| 查看: 637 | 回复: 1 | |||
jinqingxian至尊木虫 (著名写手)
有机脑力学-合成手艺学
|
[交流]
安帕来斯
|
| 谁知道安帕来斯的情况，是否允许上市？国内还是国外？销售和疗效情况如何？ |
回复此楼» 猜你喜欢
211高校2026年入学博士名额
已经有16人回复
-
海勃原辅料助力银屑病一线外用制剂开发
已经有0人回复
-
药物学论文润色/翻译怎么收费?
已经有155人回复
-
二乙烯基砜的合成路径
已经有4人回复
-
求一株[b]敲除MTAP(human)的HCT-116(人结肠癌细胞)/b]细胞
已经有0人回复
-
求助！求美国食品化学药典内容：FCC13【低聚果糖专论】
已经有0人回复
-
【2027博士申请】纳米药物递送方向
已经有5人回复
-
消耗微量API，便可预测早期研发阶段的HME工艺可行性
已经有0人回复
-
反应液中苯酐除去
已经有1人回复
-
国自然意见求助
已经有74人回复
thecoldest
金虫 (正式写手)
- 应助: 148 (高中生)
- 金币: 1773.5
- 散金: 30
- 红花: 33
- 帖子: 588
- 在线: 116.3小时
- 虫号: 1119567
- 注册: 2010-10-11
- 专业: 药物分析
★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★
小木虫: 金币+0.5, 给个红包，谢谢回帖
jinqingxian: 金币+10, 多谢 2016-01-03 16:31:01
小木虫: 金币+0.5, 给个红包，谢谢回帖
jinqingxian: 金币+10, 多谢 2016-01-03 16:31:01
|
应该是因临床试验效果不好，被原研制方Cortex放弃了 http://www.trademarkia.com/ampakine-77965906.html ABANDONED - NO STATEMENT OF USE FILED 11/5/2012 https://en.wikipedia.org/wiki/CX-516 CX-516 is an ampakine and nootropic that acts as an AMPA receptor positive allosteric modulator and is being developed by a collaboration of Cortex and Shire and Servier. It was researched as a treatment for Alzheimer's disease under the brand name Ampalex, and was also being examined as a treatment for ADHD. CX-516 was the first ampakine compound developed by Cortex and while it showed good in vitro activity and positive results in animal tests, the human trials proved disappointing due mainly to low potency and short half-life. However, CX-516 is still widely used in animal research into the ampakine drugs and is the standard reference compound that newer, more potent drugs of this class such as farampator and CX-717 are compared to. |
2楼2016-01-03 09:48:42